Mounjaro: The First GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Treatment !
Free
Log In
Overview
Activity Introduction (Brief) Build awareness and knowledge on unique Mounjaro Mode of Action, provide overview of clinical trial program with dive in on key efficacy data and the way how to start patient like Julia on treatment with Mounjaro.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
Activity Introduction (Brief) Build awareness and knowledge on unique Mounjaro Mode of Action, provide overview of clinical trial program with dive in on key efficacy data and the way how to start patient like Julia on treatment with Mounjaro.
About Organizer
- Virtual Medical Academy
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
| Mounjaro: The First GIP and GLP-1 Receptor Agonist for Type 2 Diabetes Treatment ! Certificate | Certificate | Free |
VAT 15% Included